Cadre Holdings, Inc. (CDRE)
NYSE: CDRE · Real-Time Price · USD
29.46
+0.38 (1.31%)
Apr 24, 2026, 4:00 PM EDT - Market closed

Cadre Holdings Earnings Call Transcripts

Fiscal Year 2026

Fiscal Year 2025

  • Delivered record adjusted EBITDA and strong margin expansion in 2025, driven by major contract wins and strategic acquisitions. 2026 guidance calls for double-digit revenue and EBITDA growth, with robust demand in public safety and nuclear markets despite near-term nuclear headwinds.

  • Q3 saw 42% year-over-year sales growth, margin expansion, and a $20M backlog increase, driven by strong demand and strategic execution. The acquisition of TYR Tactical and a $50M DoD contract further strengthen the outlook, with 2025 guidance reaffirmed.

  • M&A Announcement

    The acquisition of TYR Tactical adds a leading tactical gear provider with strong international presence and complementary customer base. The deal is expected to be margin accretive, enhance innovation, and expand market reach, with integration planned for the first half of 2026.

  • Investor Day 2025

    Management is shifting to an industrial model focused on high-margin verticals, with nuclear safety as a key growth driver. The nuclear segment, built via acquisitions, targets environmental cleanup, national security, and clean energy. Future growth relies on margin expansion, disciplined capital allocation, and product innovation.

  • A global safety equipment leader with dominant market shares is driving stable growth through price, operational efficiency, and targeted M&A. Expansion into nuclear markets and ongoing innovation support recurring revenue and margin expansion, with resilient demand across public safety and nuclear sectors.

  • Q2 saw 9% revenue and 10% gross profit growth, with strong demand across core segments and successful integration of a major nuclear acquisition. 2025 guidance projects continued growth, though some large contracts have shifted to 2026 due to timing.

  • Q1 2025 results surpassed expectations with strong sales, margin improvement, and a $22.4M backlog increase. The Engineering Division acquisition expands the nuclear vertical, and 2025 guidance projects double-digit revenue and EBITDA growth, with robust M&A and dividend increases.

  • M&A Announcement

    The acquisition of a leading engineering division expands international reach, doubles global scale, and enhances product offerings in nuclear safety, robotics, and nuclear medicine. Management expects margin improvement, operational synergies, and further M&A opportunities, with closing targeted for the first half of the year.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Powered by